Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 11Phase 1/2 6Phase NA 2Phase 2/3 2Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 10Breast 6Other hematologic neoplasm 4Genitourinary 4Gynecologic 3Myeloid 2Lymphoid 2Head & Neck 2Tumor-Agnostic 1Thoracic 1Endocrine 1

Conditions

Myelodysplastic Syndromes 2Myeloproliferative Disorders 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1

Interventions

Cyclophosphamide 21fludarabine phosphate 15Cyclosporine 13Antilymphocyte Serum 13Peripheral Blood Stem Cell Transplantation 12Busulfan 12Whole-Body Irradiation 11Mycophenolic Acid 10Filgrastim 8fludarabine 7Methotrexate 7Melphalan 7Therapeutics 5Radiotherapy 5Cytarabine 5Blood Specimen Collection 5Tacrolimus 4Psychiatric Rehabilitation 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4thymoglobulin 3Stem Cell Transplantation 3Palliative Care 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Flow Cytometry 3Dexamethasone 3Behavior Therapy 3Aprepitant 3sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Injections × Myeloid × Clear all
NCT01804101 2018-05-25

Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase NA Completed
48 enrolled 9 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT02121418 2018-04-13

Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

University of Washington

Phase NA Completed
12 enrolled 10 charts
Myeloid

Myelodysplastic Syndromes, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡